Growth Metrics

Bio-Techne (TECH) Shareholder's Equity Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.34%
Dec 31, 2025 3.25%
Sep 30, 2025 3.93%
Jun 30, 2025 4.10%
Mar 31, 2025 5.61%
Dec 31, 2024 6.88%
Sep 30, 2024 9.10%
Jun 30, 2024 9.60%
Mar 31, 2024 9.18%
Dec 31, 2023 8.65%
Sep 30, 2023 11.55%
Jun 30, 2023 12.50%
Mar 31, 2023 13.53%
Dec 31, 2022 11.35%
Sep 30, 2022 14.25%
Jun 30, 2022 13.43%
Mar 31, 2022 14.34%
Dec 31, 2021 15.80%
Sep 30, 2021 14.07%
Jun 30, 2021 13.34%
Mar 31, 2021 13.51%
Dec 31, 2020 15.33%
Sep 30, 2020 14.45%
Jun 30, 2020 13.30%
Mar 31, 2020 12.46%
Dec 31, 2019 14.11%
Sep 30, 2019 9.46%
Jun 30, 2019 9.85%
Mar 31, 2019 10.35%
Dec 31, 2018 8.59%
Sep 30, 2018 9.81%
Jun 30, 2018 8.41%
Mar 31, 2018 8.87%
Dec 31, 2017 6.73%
Sep 30, 2017 6.56%
Jun 30, 2017 6.09%
Mar 31, 2017 5.33%
Dec 31, 2016 5.96%
Sep 30, 2016 7.20%
Jun 30, 2016 6.03%
Mar 31, 2016 5.84%
Dec 31, 2015 7.23%
Sep 30, 2015 7.18%
Jun 30, 2015 7.89%
Mar 31, 2015 8.36%
Dec 31, 2014 11.16%
Sep 30, 2014 10.42%
Jun 30, 2014 10.71%
Mar 31, 2014 11.12%
Dec 31, 2013 11.37%
Sep 30, 2013 11.55%
Jun 30, 2013 13.70%
Jun 30, 2012 13.90%